Mirna Therapeutics, Inc.

Mirna Therapeutics, Inc. 2150 Woodward Street Austin, TX 78744
Locations Update This Record Cases by Outcome Cases by Type	SEC CIK 1527599

Add a document

Description
Summary
Document Type	Academic Paper Corporate Document - Internal Corporate Document - Public Court Document Equity Research Government Document - Federal Government Document - State Government Document - Local FBI File Public Records Request Response - FOIA Public Records Request Response - State Non-Profit Report Police Report White Paper
Document Date
Document Source
Source URL
File
	If you would like to be credited for contributing this document, make sure to sign in or sign up first. Once uploaded, your document may not be immediately visible to the public as we review each document for legal issues. Thanks for your patience!

Go Pro to view an analysis and graphs of case roles, types and more.

Mirna Therapeutics, Inc. has not been involved in any litigation in the PlainSite database.

Inside Counsel (0)

Go Pro to view corporate inside counsel.

Outside Counsel (5)

	Last Name	First Name	Middle Name	Firm	Location
	Adams	Lisa		Xerox Corporation
	Landrum	Charles	P.	Fulbright & Jaworski, LLP	Austin, TX
	Shishima	Gina		Fulbright & Jaworski, LLP	Austin, TX
	WEST	SEAPORT		FOLEY HOAG LLP
	Wilson	Mark	Wells	Klarquist Sparkman, LLP	Portland, OR

5 Rows Total

Filter By Form All Records 10-K 10-Q 3 3/A 4 424B3 424B4 424B5 425 5 8-A12B 8-K 8-K/A CERTNAS CORRESP CT ORDER D DEF 14A DEFA14A DRS DRS/A DRSLTR EFFECT FWP S-1 S-1/A S-3 S-3/A S-4 S-4/A S-8 SC 13D SC 13D/A SC 13G SC 13G/A UPLOAD From To

	Date	Entity	Form Number	Description
	1/29/2026		8-K/A
	1/23/2026		SCHEDULE 13G
	1/20/2026		8-K	Current report pursuant to Section 13 or 15(d)
	12/16/2025		8-K	Current report pursuant to Section 13 or 15(d)
	11/26/2025		8-K	Current report pursuant to Section 13 or 15(d)
	11/13/2025		SCHEDULE 13G/A
	11/13/2025		10-Q
	11/12/2025		DEF 14A
	11/12/2025		ARS
	10/31/2025	Dooley Mary Beth	4	Statement of changes in beneficial ownership of securities
	8/20/2025		EFFECT
	8/18/2025		CORRESP
	8/15/2025		S-3/A
	8/13/2025		UPLOAD
	8/8/2025		S-3
	8/7/2025		10-Q
	5/8/2025		10-Q
	4/30/2025		10-K/A
	4/29/2025	Shea Richard P	4	Statement of changes in beneficial ownership of securities
	4/29/2025	Flynn, James P.	4	Statement of changes in beneficial ownership of securities
	4/3/2025	Dooley Mary Beth	4	Statement of changes in beneficial ownership of securities
	3/6/2025		10-K	Annual report pursuant to Section 13 or 15(d)
	2/25/2025		SCHEDULE 13G/A
	2/21/2025		8-K	Current report pursuant to Section 13 or 15(d)
	2/4/2025	Dooley Mary Beth	4	Statement of changes in beneficial ownership of securities
	1/14/2025		8-K	Current report pursuant to Section 13 or 15(d)
	12/23/2024		8-K	Current report pursuant to Section 13 or 15(d)
	12/5/2024		8-K	Current report pursuant to Section 13 or 15(d)
	11/14/2024		SC 13G/A
	11/12/2024		S-8
	11/12/2024		S-8
	11/12/2024		8-K	Current report pursuant to Section 13 or 15(d)
	11/12/2024		10-Q
	11/6/2024		DEF 14A
	11/5/2024		ARS
	10/30/2024	Dooley Mary Beth	4	Statement of changes in beneficial ownership of securities
	8/8/2024		8-K	Current report pursuant to Section 13 or 15(d)
	8/8/2024		10-Q
	5/16/2024		SC 13D/A
	5/14/2024		8-K	Current report pursuant to Section 13 or 15(d)
	5/14/2024		10-Q
	4/29/2024		10-K/A
	4/22/2024		144	Notice of proposed sale of securities pursuant to Rule 144 under...
	4/18/2024		SC 13G
	4/4/2024	Dooley Mary Beth	4	Statement of changes in beneficial ownership of securities
	4/4/2024	Awad Antoine	4	Statement of changes in beneficial ownership of securities
	3/21/2024		8-K	Current report pursuant to Section 13 or 15(d)
	3/21/2024	Flynn, James P.	4	Statement of changes in beneficial ownership of securities
	3/21/2024	Dooley Mary Beth	3	Initial statement of beneficial ownership of securities
	3/21/2024	Flynn, James P.	3	Initial statement of beneficial ownership of securities

614 Rows Total	Page 1 of 13 | Go To

	Date Recorded	Party	Role	Document Type	Document No.	Invention Title
	7/18/2017	Bioo Scientific Corporation	Assignee	Application Publication Patent	12479747 20090306194 8900627	Novel Compositions For The In Vivo Delivery Of Rnai Agents Novel Compositions For The In Vivo Delivery Of Rnai Agents Novel Compositions For The In Vivo Delivery Of Rnai Agents
	10/25/2016	Bader, Andreas	Assignor	Application Publication	15298887 20170035797	Combination Cancer Treatments Utilizing Synthetic Oligonucleotides And E... Combination Cancer Treatments Utilizing Synthetic Oligonucleotides And E...
	10/25/2016	Kelnar, Kevin	Assignor	Application Publication	15298887 20170035797	Combination Cancer Treatments Utilizing Synthetic Oligonucleotides And E... Combination Cancer Treatments Utilizing Synthetic Oligonucleotides And E...
	10/25/2016	Zhao, Jane	Assignor	Application Publication	15298887 20170035797	Combination Cancer Treatments Utilizing Synthetic Oligonucleotides And E... Combination Cancer Treatments Utilizing Synthetic Oligonucleotides And E...
	4/19/2016	Asuragen, Inc.	Assignor	Application Publication Patent	15132874 20160222385 9540645	Compositions And Methods Related To Mirna Modulation Of Neovascularizati... Compositions And Methods Related To Mirna Modulation Of Neovascularizati... Compositions And Methods Related To Mirna Modulation Of Neovascularizati...
	3/7/2016	Brown, David	Assignor	Application Publication	14938350 20160060629	Synthetic Mimics Of Mir-124 Synthetic Mimics Of Mir-124
	3/7/2016	Kelnar, Kevin	Assignor	Application Publication	14938350 20160060629	Synthetic Mimics Of Mir-124 Synthetic Mimics Of Mir-124
	3/7/2016	Brown, David	Assignor	Application Publication Patent	14938350 20160060629 9611478	Synthetic Mimics Of Mir-124 Synthetic Mimics Of Mir-124 Synthetic Mimics Of Mir-124
	3/7/2016	Kelnar, Kevin	Assignor	Application Publication Patent	14938350 20160060629 9611478	Synthetic Mimics Of Mir-124 Synthetic Mimics Of Mir-124 Synthetic Mimics Of Mir-124
	2/23/2016	Bader, Andreas	Assignor	Application Publication	14736177 20150272981	Combination Cancer Treatments Utilizing Micrornas And Egfr-tki Inhibitor... Combination Cancer Treatments Utilizing Micrornas And Egfr-tki Inhibitor...
	2/23/2016	Kelnar, Kevin	Assignor	Application Publication	14736177 20150272981	Combination Cancer Treatments Utilizing Micrornas And Egfr-tki Inhibitor... Combination Cancer Treatments Utilizing Micrornas And Egfr-tki Inhibitor...
	2/23/2016	Zhao, Jane	Assignor	Application Publication	14736177 20150272981	Combination Cancer Treatments Utilizing Micrornas And Egfr-tki Inhibitor... Combination Cancer Treatments Utilizing Micrornas And Egfr-tki Inhibitor...
	12/10/2015	Bader, Andreas	Assignor	Application Publication	14946456 20160151406	Combination Cancer Therapy With C-met Inhibitors And Synthetic Oligonucl... Combination Cancer Therapy With C-met Inhibitors And Synthetic Oligonucl...
	12/10/2015	Guerrero, Adriana	Assignor	Application Publication	14946456 20160151406	Combination Cancer Therapy With C-met Inhibitors And Synthetic Oligonucl... Combination Cancer Therapy With C-met Inhibitors And Synthetic Oligonucl...
	12/10/2015	Zhao, Jane	Assignor	Application Publication	14946456 20160151406	Combination Cancer Therapy With C-met Inhibitors And Synthetic Oligonucl... Combination Cancer Therapy With C-met Inhibitors And Synthetic Oligonucl...
	11/5/2015	Brown, David	Assignor	Application Publication	14933118 20160053264	Synthetic Mimics Of Mir-34 Synthetic Mimics Of Mir-34
	11/5/2015	Kelnar, Kevin	Assignor	Application Publication	14933118 20160053264	Synthetic Mimics Of Mir-34 Synthetic Mimics Of Mir-34
	7/24/2015	Bader, Andreas	Assignor	Application Publication	14313471 20140378528	Biomarkers Of Mir-34 Activity Biomarkers Of Mir-34 Activity
	7/24/2015	Zhao, Jane	Assignor	Application Publication	14313471 20140378528	Biomarkers Of Mir-34 Activity Biomarkers Of Mir-34 Activity
	7/24/2015	Kim, Sinil	Assignor	Application Publication	14676308 20160136181	Microrna Dosing Regimens Microrna Dosing Regimens
	6/16/2015	Brown, David	Assignor	Application Publication Patent	14081295 20140107182 9371526	Fuel Pump For An Internal Combustion Engine Synthetic Mimics Of Mir-34 Synthetic Mimics Of Mir-34
	6/16/2015	Kelnar, Kevin	Assignor	Application Publication Patent	14081295 20140107182 9371526	Fuel Pump For An Internal Combustion Engine Synthetic Mimics Of Mir-34 Synthetic Mimics Of Mir-34
	6/16/2015	Asuragen, Inc.	Assignor	Application Application Publication Publication Application	13602933 14704458 20150344880 20130065951 9365852	Compositions And Methods Related To Mirna Modulation Of Neovascularizati... Compositions And Methods Related To Mirna Modulation Of Neovascularizati...
	3/6/2015	Bader, Andreas	Assignor	Application Publication Patent	14634243 20150246070 9517245	Rifle Hand Guard Sorafenib-microrna Combination Therapy For Liver Cancer Sorafenib-microrna Combination Therapy For Liver Cancer
	3/6/2015	Zhao, Jane	Assignor	Application Publication Patent	14634243 20150246070 9517245	Sorafenib-microrna Combination Therapy For Liver Cancer Sorafenib-microrna Combination Therapy For Liver Cancer Rifle Hand Guard
	4/18/2014	Bader, Andreas	Assignor	Application Publication	14215669 20140308274	Combination Cancer Treatments Utilizing Synthetic Oligonucleotides And E... Combination Cancer Treatments Utilizing Synthetic Oligonucleotides And E...
	4/18/2014	Kelnar, Kevin	Assignor	Application Publication	14215669 20140308274	Combination Cancer Treatments Utilizing Synthetic Oligonucleotides And E... Combination Cancer Treatments Utilizing Synthetic Oligonucleotides And E...
	4/18/2014	Zhao, Jane	Assignor	Application Publication	14215669 20140308274	Combination Cancer Treatments Utilizing Synthetic Oligonucleotides And E... Combination Cancer Treatments Utilizing Synthetic Oligonucleotides And E...
	4/18/2014	Bader, Andreas	Assignor	Application Publication	14212105 20140309278	Combination Cancer Treatments Utilizing Micrornas And Egfr-tki Inhibitor... Combination Cancer Treatments Utilizing Micrornas And Egfr-tki Inhibitor...
	4/18/2014	Kelnar, Kevin	Assignor	Application Publication	14212105 20140309278	Combination Cancer Treatments Utilizing Micrornas And Egfr-tki Inhibitor... Combination Cancer Treatments Utilizing Micrornas And Egfr-tki Inhibitor...
	4/18/2014	Zhao, Jane	Assignor	Application Publication	14212105 20140309278	Combination Cancer Treatments Utilizing Micrornas And Egfr-tki Inhibitor... Combination Cancer Treatments Utilizing Micrornas And Egfr-tki Inhibitor...
	3/13/2012	Brown, David	Assignor	Application Publication Patent	13365646 20120276627 9222085	Synthetic Mimics Of Mir-124 Synthetic Mimics Of Mir-124 Synthetic Mimics Of Mir-124
	3/13/2012	Kelnar, Kevin	Assignor	Application Publication Patent	13365646 20120276627 9222085	Synthetic Mimics Of Mir-124 Synthetic Mimics Of Mir-124 Synthetic Mimics Of Mir-124
	3/13/2012	Brown, David	Assignor	Application Publication Patent	13365676 20120288933 8586727	Synthetic Mimics Of Mir-34 Synthetic Mimics Of Mir-34 Synthetic Mimics Of Mir-34
	3/13/2012	Kelnar, Kevin	Assignor	Application Publication Patent	13365676 20120288933 8586727	Synthetic Mimics Of Mir-34 Synthetic Mimics Of Mir-34 Synthetic Mimics Of Mir-34
	4/13/2011	Ovcharenko, Dmitriy	Assignor	Application Publication	11967639 20090163430	Functions And Targets Of Let-7 Micro Rnas Functions And Targets Of Let-7 Micro Rnas
	4/13/2011	Kelnar, Kevin	Assignor	Application Publication	11967639 20090163430	Functions And Targets Of Let-7 Micro Rnas Functions And Targets Of Let-7 Micro Rnas
	2/24/2010	Brown, David	Assignor	Application Publication	12616616 20100179213	Methods and Compositions Involving miRNAs In Cancer Stem Cells Methods and Compositions Involving miRNAs In Cancer Stem Cells
	2/24/2010	Shelton, Jeffrey	Assignor	Application Publication	12616616 20100179213	Methods and Compositions Involving miRNAs In Cancer Stem Cells Methods and Compositions Involving miRNAs In Cancer Stem Cells
	2/24/2010	Kelnar, Kevin	Assignor	Application Publication	12616616 20100179213	Methods and Compositions Involving miRNAs In Cancer Stem Cells Methods and Compositions Involving miRNAs In Cancer Stem Cells
	2/24/2010	Wiggins, Jason	Assignor	Application Publication	12616616 20100179213	Methods and Compositions Involving miRNAs In Cancer Stem Cells Methods and Compositions Involving miRNAs In Cancer Stem Cells
	2/24/2010	Patrawala, Lubna	Assignor	Application Publication	12616616 20100179213	Methods and Compositions Involving miRNAs In Cancer Stem Cells Methods and Compositions Involving miRNAs In Cancer Stem Cells
	2/24/2010	Bader, Andreas G.	Assignor	Application Publication	12616616 20100179213	Methods and Compositions Involving miRNAs In Cancer Stem Cells Methods and Compositions Involving miRNAs In Cancer Stem Cells
	2/24/2010	Volz, Stephanie	Assignor	Application Publication	12616616 20100179213	Methods and Compositions Involving miRNAs In Cancer Stem Cells Methods and Compositions Involving miRNAs In Cancer Stem Cells
	12/10/2009	Asuragen, Inc.	Assignor	Application Application Application Application Application Application Application Application Application Application Application Application Application Publication Publication Publication Publication Publication Publication Publication Publication Publication Publication Publication Publication Publication Patent ...and 4 more	12437899 12340329 12125412 12134932 12112291 12479747 12124394 12167492 11967639 12120388 12125675 12325917 11967663 20090163434 20090306194 20090163435 20090131356 20090163430 20090192102 20090131354 20090192111 20090175827 20090281167 20090192114 20090232893 20090227533 8071562 ...and 4 more	miR-16 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENT... Mir-124 Regulated Genes And Pathways As Targets For Therapeutic Interven... miR-34 Regulated Genes and Pathways as Targets for Therapeutic Intervent... miR-126 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVEN... Novel Compositions For The In Vivo Delivery Of Rnai Agents miR-143 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVEN... miR-10 Regulated Genes and Pathways as Targets for Therapeutic Intervent... miR-21 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENT... Compositions And Methods Related To Mirna Modulation Of Neovascularizati... miR-16 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENT... Mir-124 Regulated Genes And Pathways As Targets For Therapeutic Interven... Functions And Targets Of Let-7 Micro Rnas miR-15, miR-26, miR-31, miR-145, miR-147, miR-188, miR-215, miR-216, miR... miR-126 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVEN... miR-200 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVEN... Novel Compositions For The In Vivo Delivery Of Rnai Agents miR-21 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENT... Compositions And Methods Related To Mirna Modulation Of Neovascularizati... miR-20 Regulated Genes and Pathways as Targets for Therapeutic Intervent... Mir-124 Regulated Genes And Pathways As Targets For Therapeutic Interven... Functions And Targets Of Let-7 Micro Rnas miR-15, miR-26, miR-31, miR-145, miR-147, miR-188, miR-215, miR-216, miR... miR-34 Regulated Genes and Pathways as Targets for Therapeutic Intervent... miR-200 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVEN... Novel Compositions For The In Vivo Delivery Of Rnai Agents miR-143 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVEN... miR-10 Regulated Genes and Pathways as Targets for Therapeutic Intervent... ...and 4 more

45 Rows Total

	Date Recorded	Party	Role	Document Type	Document No.	Image
	11/28/2012	Asuragen, Inc.	Assignor	Application	77434269
	11/28/2012	Asuragen, Inc.	Assignor	Trademark	0
	11/28/2012	Asuragen, Inc.	Assignor	Trademark	0
	11/28/2012	Asuragen, Inc.	Assignor	Application	77434269
	11/28/2012	Asuragen, Inc.	Assignor	Trademark	4280074
	11/28/2012	Asuragen, Inc.	Assignor	Application	77434269
	11/28/2012	Asuragen, Inc.	Assignor	Trademark	4280074
	11/28/2012	Asuragen, Inc.	Assignor	Application	77434269

8 Rows Total

Corporate Family (56)

Track Corporate Family

• Alleva Lawrence M, None
• Atlas Venture Fund IX, L.P., None
• Awad Antoine, None
• Barbosa, Miguel, None
• Barrett M James, None
• Barrett, Peter, None
• Barris Peter J, None
• Baskett, Forest, None
• Beloff Gregg, None
• Brennan, Aoife, None
• Burgess Michael F., None
• Cable Car Capital LLC, None
• Cancer Prevention & Research Institute of Texas, None
• DeYoung Casi, None
• Dooley Mary Beth, None
• Florence Anthony A. Jr., None
• Flynn, James P., None
• Fuhrman Alan, None
• Gengos Andrew, None
• Ginkgo Bioworks, Inc., None
• Greenleaf Peter, None
• Guiterrez-Ramos Jose Carlos, None
• Heffernan Michael Thomas, None
• Hurter Patricia N., None
• Irvin Jon, None
• Isaly Samuel D, None
• Jensen Michael Vangsted, None
• Jones, Elaine V., None
• Kelly-Croswell Lisa, None
• Kerins Patrick J, None
• Khuong Chau Quang, None
• Kim, Sinil, None
• Kolluri Krishna Kittu, None
• Lammers, Paul, None
• Leschly Nick, None
• Mathers Edward T, None
• Mehra Anand, None
• Miller Paul Francis, None
• Mott, David M., None
• Nea Partners 14 L.p., None
• New Enterprise Associates 14 L.p., None
• Nisen Perry, None
• O'Neill Vincent, None
• Orbimed Advisors, LLC, None
• Pfizer, Inc., None
• Plevy Scott Eric, None
• Powell, Michael, None
• Riese, Richard J., None
• Sandell Scott D, None
• Shea Richard P, None
• Shegog Todd, None
• Siegall, Clay B., None
• Sonsini Peter W., None
• Viswanathan, Ravi, None
• Weller Harry R, None
• Winkler, Matthew, None

Subsidiaries

• Alleva Lawrence M
• Barbosa, Miguel
• DeYoung Casi
• Fuhrman Alan
• Irvin Jon
• Jones, Elaine V.
• Kim, Sinil
• Lammers, Paul
• Powell, Michael
• Siegall, Clay B.
• Winkler, Matthew
• Mathers Edward T
• Mehra Anand
• Barrett M James
• Barris Peter J
• Baskett, Forest
• Florence Anthony A. Jr.
• New Enterprise Associates 14 L.p.
• Kerins Patrick J
• Kolluri Krishna Kittu
• Mott, David M.
• Sandell Scott D
• Sonsini Peter W.
• Viswanathan, Ravi
• Weller Harry R
• Pfizer, Inc.
• Greenleaf Peter
• O'Neill Vincent
• Nisen Perry
• Barrett, Peter
• Khuong Chau Quang
• Shea Richard P
• Leschly Nick
• Gengos Andrew
• Orbimed Advisors, LLC
• Miller Paul Francis
• Brennan, Aoife
• Shegog Todd
• Guiterrez-Ramos Jose Carlos
• Hurter Patricia N.
• Plevy Scott Eric
• Riese, Richard J.
• Beloff Gregg
• Burgess Michael F.
• Heffernan Michael Thomas
• Nea Partners 14 L.p.
• Cancer Prevention & Research Institute of Texas
• Isaly Samuel D
• Atlas Venture Fund IX, L.P.
• Ginkgo Bioworks, Inc.
• Awad Antoine
• Kelly-Croswell Lisa
• Jensen Michael Vangsted
• Cable Car Capital LLC
• Flynn, James P.
• Dooley Mary Beth

Sign in to add additional links.

Incoming Payments

This organization has not disclosed any incoming payments from lobbying groups.

Outgoing Payments

This organization has not disclosed any outgoing payments to lobbying groups.